Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print December 8, 2005, DOI:10.2164/jandrol.05136

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
27/3/335    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agarwal, A.
Right arrow Articles by Raina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, A.
Right arrow Articles by Raina, R.

ROLE OF OXIDATIVE STRESS IN PATHOPHYSIOLOGY OF ERECTILE DYSFUNCTION

Ashok Agarwal , Kalyana C. Nandipati , Rakesh K. Sharma , Craig D. Zippe , and Rupesh Raina

Erectile dysfunction (ED) is a highly prevalent and often underestimated problem in the general population. Systemic risk factors such as diabetes, hypertension and hyperlipidemia increase the incidence of erectile dysfunction. The pathophysiology of ED is multifactorial, and endothelial dysfunction appears to play a key role. Nitric oxide released from the endothelium is the principle mediator involved in normal erectile response. Decreased production of NO from the damaged endothelium or increased destruction at the site of action potentially can produce ED. Recently, oxidative stress has been implicated in endothelial damage or increased destruction of NO. However, the precise site of origin of these free radicals and their interactions with the endothelium is unclear. The lack of our understanding and the paucity of reports have made this topic as an interesting future research option. Oxidative stress has been implicated as one of the major causes of ED. The introduction of oral phosphodiesterase inhibitors has completely changed the treatment of ED. Initial animal studies demonstrated the beneficial effect of combination therapy with antioxidants (vitamin E) and sildenafil. This may help improve the efficacy of oral PDE-5 inhibitors in the near future. In addition, gene therapy and NO donors may also play important roles.




This article has been cited by other articles:


Home page
 J AndrolHome page
S. S. Kasturi, J. Tannir, and R. E. Brannigan
The Metabolic Syndrome and Male Infertility
J Androl, May 1, 2008; 29(3): 251 - 259.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by The American Society of Andrology.